Digirad Corporation announced that it has completed its previously announced strategic partnership and investment into Perma-Fix Medical S.A. Under this partnership, Digirad invested $1 million into Perma-Fix Medical S.A. The investment constituted approximately 5.4% of the outstanding common shares of Perma-Fix Medical S.A. As part of the partnership and investment, Digirad appointed Matt Molchan, President and CEO of Digirad Corporation, to Perma-Fix Medical S.A.'s Supervisory Board.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.5 PLN | 0.00% | +4.84% | +221.78% |
1st Jan change | Capi. | |
---|---|---|
+221.78% | 2.12M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- RNT Stock
- News Private Rented Sector S.A.
- Matt Molchan to Join Supervisory Board of Perma Fix Medical SA